Skip to main content

Table 1 Spontaneous apoptosis indices, MCL1, BCL2, BCL-XL gene expression in cases and controls

From: Spontaneous apoptosis and BCL2 gene expression as predictors of early death and short overall survival in acute leukemia patients: a prospective, case cohort study

  Control AML ALL P Post hoc test*
Annexine V 1.1 (0.1–1.5) 4.2 (0.3–13.6) 14.3 (2.2–18.6)  < 0.001 Control versus ALL < 0.00
AML versus ALL < 0.001
Control versus AML < 0.001
Anexine&PI 0.3 (0.1–0.9) 5.3 (0.6–17.1) 11.6 (5.9–24.1)  < 0.001
Total apoptosis 1.6 (0.3–1.9) 9.7 (1.7–19.3) 22.6 (14.8–38.0)  < 0.001
MCL1 1.7 (0.2–2.9) 2.0 (0.2–17.1) 3.2 (0.1–8.9) NS  
BCL2 0.8 (0.2–4.4) 2.4 (0–29.7) 3.9 (0.2–16.6) NS  
BCL-XL 0.7 (0.3–5.4) 2.0 (0–9.2) 3.1 (0.0–6.3) NS  
  1. Results are expressed as medians and ranges. Kruskal–wallis tests with Dunn–Bonferroni post hoc method were applied
  2. *Results of the post hoc test were the same for all apoptosis indices
  3. Propidium Iodide
  4. Significant P values are written in bold; NS, not significant